Authors: Jeremic, B Shibamoto, Y Acimovic, L Nikolic, N Dagovic, A Aleksandrovic, J Radosavljevic-Asic, G

Citation: B. Jeremic et al., Second cancers occurring in patients with early stage non-small-cell lung cancer treated with chest radiation therapy alone, J CL ONCOL, 19(4), 2001, pp. 1056-1063

Authors: Shibamoto, Y Jeremic, B Acimovic, L Milicic, B Nikolic, N

Citation: Y. Shibamoto et al., Influence of interfraction interval on the efficacy and toxicity of hyperfractionated radiotherapy in combination with concurrent daily chemotherapy in stage III non-small-cell lung cancer, INT J RAD O, 50(2), 2001, pp. 295-300

Authors: Jeremic, B Shibamoto, Y Acimovic, L Milicic, B Milisavljevic, S Nikolic, N Dagovic, A Aleksandrovic, J Radosavljevic-Asic, G

Citation: B. Jeremic et al., Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/etoposide chemotherapy in stage III non-small-cell lung cancer: A randomized trial, INT J RAD O, 50(1), 2001, pp. 19-25

Authors: Baskic, D Acimovic, L Samardzic, G Vujanovic, NL Arsenijevic, NN

Citation: D. Baskic et al., Blood monocytes and tumor-associated macrophages in human cancer: differences in activation levels, NEOPLASMA, 48(3), 2001, pp. 169-174

Authors: Jeremic, B Shibamoto, Y Acimovic, L Milisavljevic, S

Citation: B. Jeremic et al., Hyperfractionated radiotherapy for clinical stage II non-small cell lung cancer, RADIOTH ONC, 51(2), 1999, pp. 141-145